Prolynx Incis A Clinical Stagebiopharmaceutical Company Based In San Franciscocafounded In 2009Thecompany Specializes In Developing Long Acting Therapeutics Through Its Proprietary Drug Delivery Technologywhich Extends Thehalf Lifeof Drugs For Sustained And Controlled Releasethecoreinnovation Of Prolynx Is Its I Eliminativedrug Delivery Systemthis System Uses Self Cleaving Linkers That Releasedrugs At Specific Ratesallowing For Thecovalent Attachment Of Peptidesproteinsor Small Molecules To Macromolecular Carriers Likehydrogelsthis Technology Enables Customizablereleasekinetics And Thecreation Of Biodegradabledepots That Degradeafter Drug Releaseprolynx Also Collaborates With Pharmaceutical Companies And Academic Researchersoffering Licensing Opportunities For Its Preclinical And Clinical Candidates
No conferences found for this company.
| Company Name | Prolynx Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
